Network meta-analysis of margin threshold for women with ductal carcinoma in situ

Journal of the National Cancer Institute

Volumn 104, Issue 7, 2012, Pages 507-516

  Wang, Shi Yi ^a   Chu, Haitao ^a   Shamliyan, Tatyana ^a,b   Jalal, Hawre ^a   Kuntz, Karen M ^a   Kane, Robert L ^a,b   Virnig, Beth A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Minnesota Evidence based Practice Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; BREAST TUMOR; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; STATISTICAL ANALYSIS; TUMOR RECURRENCE;

BAYES THEOREM; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; MARKOV CHAINS; MASTECTOMY, SEGMENTAL; MONTE CARLO METHOD; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO;

EID: 84859516366     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs142     Document Type: Review

References (63)

1. Neuschatz AC, DiPetrillo T, Safaii H, et al. Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast. Int J Cancer. 2001;96(suppl):97-104.
2. Silverstein MJ, Buchanan C. Ductal carcinoma in situ: USC/Van Nuys prognostic index and the impact of margin status. Breast. 2003;12(6):457-471. (Pubitemid 38008660)
3. Holland PA, Gandhi A, Knox WF, et al. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer. 1998;77(1):110-114. (Pubitemid 28029781)
4. Wang SY, Shamliyan T, Virnig BA, Kane R. Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat. 2011;127(1):1-14.
5. Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg. 2009;209(5):608-613.
6. Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol. 2010;17(2):558-563.
7. Baxter NN, Virnig BA, Durham SB, et al. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6):443-448. (Pubitemid 38443647)
8. Carlson RW, Goldstein LJ, Gradishar WJ, et al. NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network. Oncology. 1996;10(11 suppl):47-75.
9. Carlson RW, Allred DC, Anderson BO, et al. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer V.1.2009. Fort Washington, PA: National Comprehensive Cancer Network; 2009.
10. Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170-178.
11. Virnig BA, Shamliyan TA, Tuttle TM, et al. Diagnosis and Management of Ductal Carcinoma In Situ. Evidence Report/Technology Assessments. No. 185. AHRQ Publication No. 09-E018. Rockville, MD: Agency for Healthcare Research and Quality; 2009. http://www.ahrq.gov/downloads/pub/evidence/pdf/dcis/dcis.pdf. Accessed July 30, 2010.
12. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105-3124. (Pubitemid 39334902)
13. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331(7521):897-900. (Pubitemid 41502718)
14. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002;21(16):2313-2324.
15. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. (Pubitemid 17189972)
16. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820-826. (Pubitemid 27465551)
17. Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat Med. 1995;14(24):2685-2699. (Pubitemid 26014258)
18. Nixon RM, Bansback N, Brennan A. Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. Stat Med. 2007;26(6):1237-1254. (Pubitemid 46380839)
19. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci. 1992;7(4):457-472.
20. Parmigiani G. Modeling in Medical Decision Making: A Bayesian Approach. New York, NY: Wiley; 2002.
21. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381-3387. (Pubitemid 46638893)
22. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol. 2001;28(4):400-418. (Pubitemid 32762083)
23. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999;86(3):429-438. (Pubitemid 29347405)
24. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer. 2005;103(6):1137-1146. (Pubitemid 40328083)
25. MacAusland SG, Hepel JT, Chong FK, et al. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ. Cancer. 2007;110(12):2648-2653. (Pubitemid 350250333)
26. Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Int J Radiat Oncol Biol Phys. 2002;53(4):868-879. (Pubitemid 34722631)
27. Chan KC, Knox WF, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer. 2001;91(1):9-16. (Pubitemid 32052608)
28. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24(7):1031-1036. (Pubitemid 46638798)
29. Ben-David MA, Sturtz DE, Griffith KA, et al. Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience. Breast J. 2007;13(4):392-400. (Pubitemid 46985566)
30. Cataliotti L, Distante V, Ciatto S, et al. Intraductal breast cancer: review of 183 consecutive cases. Eur J Cancer. 1992;28A(4-5):917-920.
31. Turaka A, Freedman GM, Li T, et al. Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol. 2009;100(1):25-31.
32. Rudloff U, Brogi E, Reiner AS, et al. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. Ann Surg. 2010;251(4):583-591.
33. Ringberg A, Idvall I, Fernö M, et al. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast. Eur J Surg Oncol. 2000;26(5):444-451.
34. Tunon-de-Lara C, de-Mascarel I, Mac-Grogan G, et al. Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment-the experience of one institute. Am J Clin Oncol. 2001;24(6):531-536. (Pubitemid 33131410)
35. Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319-5324.
36. Warneke J, Grossklaus D, Davis J, et al. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. J Am Coll Surg. 1995;180(6):683-688.
37. Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R. Defining negative margins in DCIS patients treated with breast conservation therapy: the University of Chicago experience. Breast J. 2005;11(4):242-247. (Pubitemid 41026037)
38. Nakamura S, Woo C, Silberman H, et al. Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy. Am J Surg. 2002;184(5):403-409. (Pubitemid 35335945)
39. MacDonald HR, Silverstein MJ, Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005;190(4):521-525. (Pubitemid 41306068)
40. Fish EB, Chapman JA, Miller NA, et al. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Ann Surg Oncol. 1998;5(8):724-732. (Pubitemid 28565725)
41. Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results. Ann Surg. 2000;231(2):235-245. (Pubitemid 30078807)
42. Goldstein NS, Kestin L, Vicini F. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy. Am J Surg Pathol. 2000;24(8):1058-1067. (Pubitemid 30612827)
43. Rodrigues N, Carter D, Dillon D, et al. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54(5):1331-1335. (Pubitemid 35380032)
44. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol. 2008;26(8):1247-1252.
45. Salanti G, Marinho V, Higgins JP. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol. 2009;62(8):857-864.
46. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23(11):1663-1682. (Pubitemid 38765338)
47. Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol. 2009;27(10):1615-1620.
48. McCormick B, Rosen PP, Kinne D, et al. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1991;21(2):289-292.
49. Cutuli B, Teissier E, Piat JM, et al. Radical surgery and conservative treatment of ductal carcinoma in situ of the breast. Eur J Cancer. 1992;28(2-3):649-654.
50. Hiramatsu H, Bornstein BA, Recht A, et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: possible importance of family history. Cancer J Sci Am. 1995;1(1):55-61.
51. Mirza NQ, Vlastos G, Meric F, et al. Ductal carcinoma-in-situ: long-term results of breast conserving therapy. Ann Surg Oncol. 2000;7(9):656-664.
52. Weng EY, Juillard GJ, Parker RG, et al. Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer. 2000;88(7):1643-1649. (Pubitemid 30183150)
53. Dickerson K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev. 1992;14(1):154-176. (Pubitemid 23024558)
54. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. 1st ed. New York, NY: Wiley; 2009.
55. Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess. 2005;9(26):1-134.
56. Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ. 2009;338(7700):b1147.
57. Carlin BP, Louis TA. Bayesian Methods for Data Analysis. 3rd ed. Boca Raton, FL: Chapman & Hall/CRC; 2009.
58. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2003.
59. Berger JO. Bayesian Analysis. Statistical Decision Theory and Bayesian Analysis. 2nd ed. New York, NY: Springer-Verlag; 1985.
60. Carlin JB. Tutorial in biostatistics. Meta-analysis: formulating, evaluating, combining, and reporting by S-L. T. Normand, Statistics in Medicine, 18, 321-359 (1999). Stat Med. 2000;19(5):753-759.
61. Solin LJ, Fourquet A, Vicini FA, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys. 2001;50(4):991-1002. (Pubitemid 32594839)
62. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol. 2000;18(2):296-306. (Pubitemid 30056418)
63. Dick AW, Sorbero MS, Ahrendt GM, et al. Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Natl Cancer Inst. 2011;103(2):92-104.